论文部分内容阅读
早期乳腺癌联合实验组(Early Breast Cancer Trialists’CollaborativeGroup,EBCTCG)在柳叶刀杂志(Lancet2008;371:29-40)上发表文章,认为多种化学疗法作用于雌激素受体弱阳性的乳腺癌患者的远期疗效评估,以及这些疗效受年龄因素及他莫昔芬治疗的影响程度可以通过随机临床试验
The Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) published an article in The Lancet Magazine (Lancet 2008; 371: 29-40), arguing that multiple chemotherapies act on weakly positive estrogen receptor-bearing breast cancers Evaluation of the long-term efficacy of patients, and the extent of the effects of these effects on age and tamoxifen treatment can be assessed by randomized clinical trials